The effects of 4-aminopyridine on cognitive function in patients with multiple sclerosis: a pilot study
- PMID: 7936300
- DOI: 10.1212/wnl.44.9.1701
The effects of 4-aminopyridine on cognitive function in patients with multiple sclerosis: a pilot study
Abstract
4-Aminopyridine (4-AP) has a favorable effect on the disability of certain patients with MS. We investigated the effect of 4-AP on neuropsychological performance in 20 MS patients using a randomized, double-blind, placebo-controlled, crossover design. Although there was a trend for improved performance with 4-AP for two of the tests, we could not demonstrate significant effects of 4-AP on cognitive function.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical